12:00 AM
 | 
Apr 12, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

pSivida preclinical data

In a rat model of RP, low-dose, sustained-release fluocinolone acetonide delivered intravitreously by pSivida's Durasert...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >